Plandaí Biotechnology, a producer of highly bioavailable plant extracts, today announced the launch of a new, investor friendly website designed to educate the public about the company’s proprietary CRS processing system and the importance of bioavailability in nutrition.
The website is easy to navigate and provides investors with quick access to historical SEC filings and press releases. The website also has several excellent photos of the Senteeko tea estate located in South Africa, along with discussions on the nature of tea production, ongoing research, and the importance of bioavailability. Company contact information and newsletter sign up is also provided.
The benefits of delivering high concentrate bioavailable phytonutrients allow the body to more efficiently absorb the active and stable nutrients and antioxidants. For example, green tea, which is rich in antioxidants critical for protecting white and red blood cells and boosting the body’s immune system, is not readily absorbed in its natural state. According to published research, the average person needs to consume 8-10 cups of green tea in order to receive a clinical dose of the necessary gallate catechins. Plandaí’s CRS hydrodynamic process is able to alter the isomeric properties of plant material so that they are more in line with that found in human tissues, thus increasing the absorbability by up to eight times that of other extracts.
Roger Duffield, Chief Executive Officer of Plandaí, commented, “As a management team, we value the importance of educating the public about bioavailability. Billions of dollars are spent annually on supplements and vitamin-enhanced products, but these are wasted dollars if what is being consumed is not in a form that the body can absorb and process. Our new website will be a useful tool for getting timely information to shareholders and concerned consumers while also providing updates as new research is completed and we draw nearer to full production.”
Let us hear your thoughts below: